Previous work has suggested an association between cancer, inflammation, and increased IDO1 expression within tumors [31, 41], suggesting that similar to PD-L1, intratumoral inflammation may lead to adaptive resistance as a mechanism of tumor immune evasion within the tumor microenvironment. Here, IDO1 is linked to neoplasm.